Home › Ductal Carcinoma In Situ (DCIS) › NCT04169542
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
Potential Impact of the COVID -19 Pandemic on Financial Toxicity in Breast Cancer Surgical Patients: The Impact on Out of Pocket Costs, Lost Wages and Economic Strain
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Have an indication for surgical treatment of invasive breast cancer or ductal breast carcinoma in situ (DCIS) or prophylaxis in the setting of genetic mutations or strong family history * English-speaking * Able to complete consent * Able to fill out computer survey material Exclusion Criteria: * Non-English-speaking * Those with recurrent or metastatic disease or concurrent primary cancers * Patients undergoing breast conservation therapy will also be excluded from the study
About the study
This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast surgery. Post-mastectomy reconstructive patients are at high risk for financial toxicity (adverse effects of escalating health care cost on well-being). The goal of this study is to collect information about financial costs patients may have as a result of surgical treatment for cancer with or without breast reconstruction and to learn if COVID-19 affects patient costs of breast reconstruction. This may help researchers demonstrate the financial consequences of undergoing breast surgery.
What is being tested
- Questionnaire Administration (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 600 · Started: May 21, 2019
Contact the study team
- Carrie Chu, MD · Phone: 713-794-1247
Official record on ClinicalTrials.gov — NCT04169542
Locations in the U.S.
| Texas | MD Anderson in The Woodlands, Conroe M D Anderson Cancer Center, Houston MD Anderson League City, League City MD Anderson in Sugar Land, Sugar Land |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.